Omer Yavuz

Dr. Omer Yavuz

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2021 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
AMAntonia Marazioti
Antonia Marazioti
AKAnthi C Krontira
Anthi C Krontira
SBSabine J Behrend
Sabine J Behrend
GGGeorgia A Giotopoulou
Georgia A Giotopoulou
GNGiannoula Ntaliarda
Giannoula Ntaliarda
GSGeorgios Stathopoulos
Georgios Stathopoulos
Malignant pleural mesothelioma (MPM) arises from mesothelial cells lining the pleural cavity of asbestos‐exposed individuals and rapidly leads to death. MPM harbors loss‐of‐function mutations in BAP1 , NF2 , CDKN2A , and TP53 , but isolated deletion of these genes alone in mice does not cause MPM and mouse models of the disease are sparse. Here, we show that a proportion of human MPM harbor point mutations, copy number alterations, and overexpression of KRAS with or without TP53 changes. These are likely pathogenic, since ectopic expression of mutant KRAS G12D in the pleural mesothelium of conditional mice causes epithelioid MPM and cooperates with TP53 deletion to drive a more aggressive disease form with biphasic features and pleural effusions. Murine MPM cell lines derived from these tumors carry the initiating KRAS G12D lesions, secondary Bap1 alterations, and human MPM‐like gene expression profiles. Moreover, they are transplantable and actionable by KRAS inhibition. Our results indicate that KRAS alterations alone or in accomplice with TP53 alterations likely play an important and underestimated role in a proportion of patients with MPM, which warrants further exploration.

31 December 2025 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
OYOmer Yavuz
Omer Yavuz
MIMehlika Iscan
Mehlika Iscan
Background: Port catheters are indispensable in modern oncologic and medical care. Despite their benefits, complications such as skin erosion and related mechanical issues remain a significant concern. While numerous studies have explored prevention and management strategies, the influence of port reservoir thickness on these complications has not been systematically evaluated. This study investigates whether port thickness independently contributes to skin erosion risk, aiming to inform device selection and placement strategies. Patients and methods: This retrospective single-center study included 662 patients who underwent port catheter implantation at Istanbul Başakşehir Çam ve Sakura City Hospital between June 2022 and October 2024. Data on demographics, port brand, reservoir height, and revision status were analyzed. Appropriate nonparametric tests were used for group comparisons, and Spearman correlation and multivariate logistic regression were performed to assess the association between reservoir height and revision risk. A p-value < 0.05 was considered statistically significant. Results: Among 662 patients, 29 experienced skin erosion requiring revision, corresponding to a 4.4% overall revision rate. All revisions were due to skin erosion; no major or infectious complications occurred. Reservoir heights of the four port brands, 10.6 mm ( n = 257), 11.6 mm ( n = 58), 12.2 mm ( n = 219), and 13.2 mm ( n = 128), demonstrated a trend toward higher revision rates with increasing port thickness. Spearman correlation analysis demonstrated a weak but significant positive relationship between reservoir height and revision risk ( r = 0.168, p < 0.001), indicating a size-dependent trend. In multivariate logistic regression, both port reservoir height and anti-VEGF therapy emerged as independent predictors of revision. Compared with 10.6-mm ports, 12.2-mm and 13.2-mm ports were associated with 4.47- and 10.39-fold higher revision risks ( p = 0.023 and p < 0.001, respectively). Anti-VEGF therapy increased the revision risk by approximately 2.9-fold ( p = 0.022). Conclusions: Port reservoir thickness is an independent predictor of skin erosion requiring revision. Thicker ports were linked to higher complication rates, particularly in patients receiving anti-VEGF therapy, underscoring the importance of device selection and design considerations in clinical practice. These findings suggest that thinner-profile ports should be preferred when feasible. Prospective studies are needed to validate these findings and establish evidence-based recommendations for port selection and placement.

20 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MIMehlika Iscan
Mehlika Iscan
OYOmer Yavuz
Omer Yavuz
REReyhan Ertan
Reyhan Ertan
AYAli Yeginsu
Ali Yeginsu
Background: Routine chest tube placement remains common in robotic mediastinal surgery despite its association with postoperative pain. We evaluated the safety and feasibility of a protocol-driven no-drain strategy for robotic mediastinal lesion resection. Methods: This prospective study analyzed 39 consecutive procedures performed in 38 patients. A strict intraoperative safety protocol, including a submerged air leak test, was utilized to determine drain omission. Procedures were categorized into no-drain (n = 21) and drain (n = 18) groups based on protocol adherence. Results: The no-drain strategy was implemented in 53.8% of procedures, including complex cases such as thymomas and large lesions (up to 160 mm). The no-drain group was associated with lower median VAS pain scores at 12 h (2.0 vs. 5.0, p < 0.001) and shorter hospital length of stay (20.0 vs. 52.0 h, p < 0.001). No patient in the no-drain group required reintervention for residual pneumothorax. Conclusions: Omitting chest tubes using a standardized safety protocol is feasible and safe in appropriately selected patients. This strategy was associated with lower postoperative pain and a shorter hospital stay, supporting the feasibility of a short-stay recovery pathway after robotic mediastinal surgery.

1 January 2020 in Current Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
OYOmer Yavuz
Omer Yavuz
MKMurat Kapdağlı
Murat Kapdağlı
SESuat Erus
Suat Erus
PBPınar Bulutay
Pınar Bulutay
STSerhan Tanju
Serhan Tanju

3 April 2023
Verified
Other
Open access
AUAhmet M. Ulusan
Ahmet M. Ulusan
Praveen RajendranPraveen Rajendran
Praveen Rajendran
WDWan Mohaiza Dashwood
Wan Mohaiza Dashwood
OYOmer Yavuz
Omer Yavuz
SKSabeeta Kapoor
Sabeeta Kapoor
Roderick DashwoodRoderick Dashwood
Roderick Dashwood

10 May 2026 in Annali Italiani di Chirurgia
Verified
Journal Article
Open access
OYOmer Yavuz
Omer Yavuz
MIMehlika Iscan
Mehlika Iscan
EEEren Erdoğdu
Eren Erdoğdu
MKMuhammet Kertmen
Muhammet Kertmen
AYAli Yeginsu
Ali Yeginsu
AIM: Totally implantable venous access port (TIVAP) placement is routinely recommended under ultrasound guidance to reduce complications. However, in low-resource settings, the anatomical landmark technique remains widely used. Data evaluating the learning curve of landmark-based TIVAP placement through formal statistical methods are limited. METHODS: This retrospective single-center study analyzed 1285 consecutive TIVAP-related procedures, including port placement, revision, and removal, performed by a single surgeon between June 2022 and September 2025 using the anatomical landmark technique. The cohort comprised 1093 port catheter placements, 98 removals, and 67 revisions. Technical failure was defined as the inability to achieve venous cannulation or to advance the guidewire/catheter into the central venous circulation and was assessed only in procedures requiring venous access (placements and revisions), in which 27 failures occurred. Cumulative sum (CUSUM) analysis was restricted to procedures requiring venous access to evaluate performance based on technical failure rates; port removals were excluded from the failure-based CUSUM framework. Procedures were additionally stratified by technical complexity. The CUSUM inflection point was used to explore a potential transition in procedural performance. RESULTS: Technical success was achieved in 1258 of 1285 TIVAP-related procedures (97.9%). A total of 27 cases resulted in technical failure (failure rate: 2.1%), primarily due to unsuccessful venous cannulation or guidewire advancement. CUSUM analysis identified an inflection point at the 422nd case, indicating a transition from the initial learning phase to a phase of performance stabilization. Among procedures requiring venous access, technical failure rates were significantly higher in Phase 1 (cases 1–422) compared with Phase 2 (cases 423–1187) (5.2% vs. 0.7%, p < 0.001). Procedural complexity showed only minimal variation across the series, and technical performance remained stable throughout the study period. No further technical failures were observed during the final 252 consecutive procedures. Pneumothorax occurred in 5 cases (0.39% [5/1285] of all procedures; 0.43% [5/1160] of venous access procedures). CONCLUSIONS: Based on the observed learning curve, procedural stabilization in landmark-based TIVAP placement may require a higher case volume than reported previously for ultrasound-guided approaches. In this single-center, single-operator study, an inflection point at approximately 422 cases was associated with stabilization of procedural performance and a reduction in technical failure rates. These findings suggest that, in low-resource settings where ultrasound guidance is not routinely available, the landmark technique may be performed with an acceptable safety profile under standardized workflows and with adequate training and experience.